CSL Ltd
ASX:CSL
CSL Ltd
Gross Profit
CSL Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Gross Profit
$7.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Immutep Ltd
ASX:IMM
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Opthea Ltd
ASX:OPT
|
Gross Profit
-$116.8k
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mesoblast Ltd
ASX:MSB
|
Gross Profit
-$14.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Gross Profit
AU$95.4m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Gross Profit
AU$314.4m
|
CAGR 3-Years
362%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CSL Ltd's Gross Profit?
Gross Profit
7.3B
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Gross Profit amounts to 7.3B USD.
What is CSL Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
10%
Over the last year, the Gross Profit growth was 19%. The average annual Gross Profit growth rates for CSL Ltd have been 8% over the past three years , 9% over the past five years , and 10% over the past ten years .